WHC is still in active development. Read this to understand our approach.
depiction of FYOWWXMGDATDQY-UHFFFAOYSA-N.svg
tripsit

rolicyclidine

Verificar en tripsit

isomerdesign

PCPy

Verificar en isomerdesign

pubchem

Rolicyclidine

Verificar en pubchem

drugmap

Rolicyclidine

Verificar en drugmap

wiki

Rolicyclidine

Verificar en wiki

Data

InChI: InChI=1S/C16H23N/c1-3-9-15(10-4-1)16(11-5-2-6-12-16)17-13-7-8-14-17/h1,3-4,9-10H,2,5-8,11-14H2

Sinónimos: DSSTox_RID_81398,UNII-183O9O9JE3, DSSTox_CID_26167,Rolicyclidinum [INN-Latin],Rolicyclidine [INN], Roliciclidina [INN-Spanish], Roliciclidina,CHEMBL1719398, DTXSID8046167, NCGC00160464-01,183O9O9JE3,Q570183, CHEMBL1719398,CAS-2201-39-0,1-(1-phenylcyclohexyl)-pyrrolidine,Rolicyclidinum, Rolicyclidinum,1-(1-Phenylcyclohexyl)pyrrolidine,Roliciclidina,DEA No. 7458,Pyrrolidine analog of phencyclidine,PCPy, 1-(1-Phenylcyclohexyl)pyrrolidine,Pyrrolidine, 1-(1-phenylcyclohexyl)-, AC1L1X48,Roliciclidina [INN-Spanish],ROLICYCLIDINE, DSSTox_GSID_46167,SCHEMBL517928, SCHEMBL517928,Pyrrolidine, 1-(1-phenylcyclohexyl), HSDB 7636, CHEBI:60805,NCGC00160464-01,CHEBI:60805, Rolicyclidine [INN],PCP pyrrolidine analog, Pyrrolidine analog of phencyclidine, FYOWWXMGDATDQY-UHFFFAOYSA-N,2201-39-0,DB01549, Rolicyclidinum [INN-Latin], 1-(1-phenylcyclohexyl)-pyrrolidine, DEA No. 7458, PCP pyrrolidine analog, UNII-183O9O9JE3,pcpy,ROLICYCLIDINE [HSDB],DTXSID8046167,ZINC1481918, Pyrrolidine, 1-(1-phenylcyclohexyl)-, PCPy,Rolicyclidine,HSDB 7636,DSSTox_CID_26167,Tox21_111832,DSSTox_GSID_46167, DSSTox_RID_81398, 183O9O9JE3, 2201-39-0,1-(1-phenylcyclohexyl)pyrrolidine (Rolicyclidine)

Estimated data

Solubilidad: -3.038 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 90.0% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.